From 35 · formulated by a pharmacist
The full Vitant routine for women’s skin.
Five products, about two minutes morning and evening. Start at 35; at 50 your routine moves to the Prime range.

Your two minutes
The same cleanser morning and evening. Glow Serum by day, Smoothing Gel by night.
In the box
Five products. R1,470 for the set.
Foaming Cleanser 100 mlWith LactoSporin®, a postbiotic that helps balance the skin’s microbiome. Leaves skin clean, not tight.R300
Glow Serum 20 mlVitamin C 15% with ferulic acid: an antioxidant for the morning, before your SPF.R330
Smoothing Gel 20 mlBlackheads down 43% in 28 days with its AHA system, at the same 2% level.*R230
Restorative Moisturiser 50 mlComparable to 0.3% retinol over 56 days: crow’s-feet depth −18.7% (retinol −16.2%).*R410
SkinSmart Day Cream SPF 30SPF 30, tested on people, broad spectrum with UVA protection. With RetinART™ and bakuchiol.*R500Buy it with Collagen Quench Leave-on Jelly Mask: the ten-minute hydration mask. Skin hydration +24.9% in 10 minutes (placebo +16.6%).*
Collagen Quench – R430
The simple three-step start
Daily Essentials for Her
Foaming Cleanser, Restorative Moisturiser and SkinSmart Day Cream SPF 30. Morning: cleanse + SkinSmart. Evening: cleanse + Restorative.
R1,060
Shop Daily Essentials for Her – R1,060Turning 50?
Your routine moves to the Prime range.
* Smoothing Gel: ingredient study on the AHA system at 2% (SKINPERF), 24 women aged 34–64 with sensitive, blemish-prone skin, twice daily, 28 days, compared with the start.
* Restorative Moisturiser: ALGAKTIV® RetinART™ 2% (CL2022 1%) vs 0.3% retinol, Complife Italia IT0005019/21, 30 women over 40, split face, twice daily, 56 days; no significant difference between the two.
* SkinSmart Day Cream SPF 30: SPF test certificate 2866 (ISO 24444:2019, in vivo); UVA report 2700/2024-012 (ISO 24443): broad spectrum pass, UVA protection pass.
* Collagen Quench: Complife Italia, ALGAKTIV® Collage™ 3% against placebo, single application, split face, 30 women aged 40–60. Collagen Quench contains Collage™ at 3%.
